ArticleAperture neuro2024
Stable multivariate lesion symptom mapping.
Article in Aperture neuro, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Mapping of critical prosodic and phonetic networks in post-stroke apraxia of speech.bioRxiv : the preprint server for biology · 2025Article
- Post-stroke sensory hypersensitivity: insights from lesion-symptom and disconnection mapping.Brain communications · 2025Article
- Hypoperfusion regions linked to National Institutes of Health Stroke Scale scores in acute stroke.NeuroImage. Clinical · 2025Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Multivariate lesion-symptom mapping (MLSM) considers lesion information across the entire brain to predict impairments. The strength of this approach is also its weakness-considering many brain features together synergistically can uncover complex brain-behavior relationships but exposes a high-dimensional feature space that a model is expected to learn. Successfully distinguishing between features in this landscape can be difficult for models, particularly in the presence of irrelevant or redundant features. Here, we propose stable multivariate lesion-symptom mapping (sMLSM), which integrates the identification of reliable features with stability selection into conventional MLSM and describe our open-source MATLAB implementation. Usage is showcased with our publicly available dataset of chronic stroke survivors (N=167) and further validated in our independent public acute stroke dataset (N = 1106). We demonstrate that sMLSM eliminates inconsistent features highlighted by MLSM, reduces variation in feature weights, enables the model to learn more complex patterns of brain damage, and improves model accuracy for predicting aphasia severity in a way that tends to be robust regarding the choice of parameters for identifying reliable features. Critically, sMLSM more consistently outperforms predictions based on lesion size alone. This advantage is evident starting at modest sample sizes (N>75). Spatial distribution of feature importance is different in sMLSM, which highlights the features identified by univariate lesion symptom mapping while also implicating select regions emphasized by MLSM. Beyond improved prediction accuracy, sMLSM can offer deeper insight into reliable biomarkers of impairment, informing our understanding of neurobiology.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.